Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir
NCT05169580
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Sickle Cell Disease
Sickle Cell Anemia
Interventions
DRUG:
Pociredir oral capsule(s)
Sponsor
Fulcrum Therapeutics